E-Swin is recognized for developing the patented IRPL® (Intense Regulated Pulsed Light) technology. Its flagship device in ophthalmology is the E-Eye, the world's first medical device specifically designed for the treatment of dry eye caused by Meibomian gland dysfunction. The E-Eye generates perfectly calibrated and homogeneously sequenced light pulses, with energy, spectrum, and timing precisely adjusted to achieve the best possible outcome. The treatment is non-invasive, painless, and safe; each session takes only a few minutes and requires no device warm-up. The protocol is short and effective—typically 3 to 4 sessions (Day 1, Day 15, Day 45, and an optional fourth session)—with fast and cumulative effects that generally last for a minimum of six months. The E-Eye combines innovative technology, ease of use, and clinically validated results supported by multiple studies, offering specialists a reliable and long-lasting solution for dry eye management.
Showing 1 of 1 products
Get personalized guidance to find the ideal technology for your clinic's needs.
Talk to a Specialist
